Major tech and consumer stocks experienced significant price movements in premarket trading following the release of quarterly earnings reports. Apple, Roku, and Estee Lauder saw notable gains, while Roblox faced a substantial decline. The market reacted to a mix of better-than-expected financial results, revised forecasts, and strategic company announcements, highlighting investor sentiment on growth prospects and market challenges.
Other companies like Reddit and Twilio also posted strong gains, driven by user growth and robust financial performance. Conversely, Western Digital and Clorox experienced pullbacks despite some positive financial metrics, reflecting broader market concerns about consumer spending and the impact of geopolitical events.
READ MORE FROM CNBC
The premarket trading session saw significant shifts across major tech and consumer stocks as companies released their latest earnings reports. Apple Inc. led the pack with a 3.5% surge after exceeding expectations for fiscal second-quarter earnings and revenue, though iPhone sales slightly missed analyst projections. Roku Inc. jumped 7% following a stronger-than-expected first quarter, with the streaming giant projecting continued growth in adjusted EBITDA, revenue, and gross profit. Estee Lauder Companies Inc. experienced an 11% boost after reporting better-than-expected third-quarter sales and raising its annual forecast, alongside announcing further job cuts as part of a restructuring plan.
Amgen Inc. saw a slight dip of nearly 2% despite a marginal increase in its full-year forecast. Electric vehicle maker Rivian Automotive Inc. tumbled almost 3%, even as it posted a narrower first-quarter loss than anticipated and reaffirmed its 2026 delivery target. Social media platform Reddit Inc. climbed over 13%, driven by daily active users slightly surpassing estimates and a strong outlook for adjusted EBITDA in the current quarter. Moderna Inc. rose 3% after reporting a smaller-than-expected first-quarter loss and revenue that topped expectations, while reaffirming its full-year revenue growth guidance.
Roblox Corporation, the online gaming platform, suffered a significant drop of more than 23% after slashing its full-year bookings guidance. Paramount Global saw a 3% increase following a double upgrade from Morgan Stanley, citing potential benefits from an acquisition, AI-driven cost savings, and a renewed focus on streaming and studio assets. SanDisk Corporation fell 4% despite beating fiscal third-quarter earnings and providing better-than-expected guidance; its stock had previously seen substantial gains in 2026. Cloud communications software provider Twilio Inc. surged 22% after reporting strong first-quarter earnings and revenue that exceeded analyst forecasts, with an optimistic revenue outlook for the current quarter.
Clorox Company experienced a 6% decline, despite an earnings beat in its fiscal third quarter. Investors expressed concern over the company's reduced full-year profit outlook, attributed to cautious consumer spending amid rising gas prices. Monolithic Power Systems Inc. slid 3% even as it reported better-than-expected first-quarter earnings and revenue and announced a favorable outcome in a patent dispute. Western Digital Corporation's stock dropped 8%, notwithstanding strong fiscal third-quarter results and a positive fourth-quarter outlook; the company, recently rebranded as WD, has seen significant stock appreciation recently, boosted by a rival's strong earnings.
Dexcom Inc., a maker of continuous glucose monitoring systems, fell 2% despite delivering better-than-expected first-quarter earnings and revenue, while reiterating its full-year revenue forecast. Website builder GoDaddy Inc. popped 3.5% after surpassing earnings and revenue expectations for the first quarter, with free cash flow also exceeding projections. Veeva Systems Inc. shares jumped 11% on the news that it will be joining the S&P 500 index, replacing Coterra Energy. Eastman Chemical Company rose nearly 4% after its first-quarter earnings and revenue slightly exceeded analyst expectations, with potential for further upside due to the impact of the Iran war. Finally, AstraZeneca PLC, the UK-based pharmaceutical giant, fell over 1% after an FDA advisory panel recommended against its new cancer drug, though a possibility remains for its use in other programs.
